Related Experiment Video
Updated: Jun 11, 2026

09:00
Use of the Protease Fluorescent Detection Kit to Determine Protease Activity
Published on: August 4, 2009
28.4K
Rapid sepsis diagnosis with protease activity measurement
Medrxiv : the Preprint Server for Health Sciences
|August 12, 2025
Summary
We developed a novel assay using modified protease substrates and mass spectrometry for sepsis diagnosis. This rapid, cost-effective platform achieves high sensitivity and specificity for detecting human neutrophil elastase and matrix metalloproteinase activity.
Area of Science:
- Biochemistry
- Analytical Chemistry
- Clinical Diagnostics
Background:
- Human proteases are implicated in diseases like sepsis, but measuring their activity is challenging due to substrate diversity and specificity issues.
- Existing methods for protease activity profiling are complex, hindering the development of diagnostic tools.
Purpose of the Study:
- To develop an advanced assay for measuring multiple protease activities simultaneously.
- To create a sensitive and specific diagnostic tool for sepsis detection using mass spectrometry.
Main Methods:
- Chemically modified protease substrates for human neutrophil elastase (HNE) and matrix metalloproteinases (MMPs) were designed to enhance mass spectrometry specificity.
- A multiplexed assay platform was developed using these modified substrates for simultaneous quantification of protease activities.
- The assay was applied to plasma samples to analyze protease activity profiles.
Main Results:
- The assay successfully differentiated protease activities by producing distinct, non-overlapping mass-to-charge signatures of cleavage products.
- Multiplexed quantification of multiple protease activities was achieved in a single assay run.
- The assay demonstrated a diagnostic sensitivity of 88% and specificity of 87% for sepsis detection.
Conclusions:
- Novel substrate modifications and mass spectrometry enable precise differentiation and quantification of protease activities.
- This multiplexed assay platform offers a rapid, cost-effective, and robust method for sepsis diagnosis.
- The developed platform shows significant potential for broad clinical application in diagnosing protease-related conditions.

